ART in Med Ed Program

Anti-Racist Transformation (ART) in Medical Education

ART in Med Ed

In 2021, the David Geffen School of Medicine was selected to participate in the Anti-Racist Transformation in Medical Education (ART in Med Ed) program. DGSOM’s selection for participation in the three-year Anti-Racist Transformation in Medical Education (ART in Med Ed) program, one of just 11 medical schools chosen, is a milestone in its journey toward anti-racism.

Sponsored by the Josiah Macy Jr. Foundation, in partnership with the Icahn School of Medicine at Mt. Sinai, ART in Med Ed replicates a model developed by the Icahn School to dismantle systemic racism and bias in academic medicine. 

The program aims to mitigate racism in the learning and work environment of medical schools through a formal management change process that is “lifelong, people-centered, incremental and nonlinear".

About ART in Med Ed

Cohort Members

  • Eraka Bath, MD, senior adviser to the Anti-Racism Roadmap
  • Medell Briggs-Malonson, MD, MPH, chief of Health Equity, Diversity and Inclusion
  • Enrico Castillo, MD, MSHPM, associate director of Residency Education, faculty lead and Community & Global Psychiatry, Jane & Terry Semel Institute for Neuroscience & Human Behavior
  • Stephanie Fisher, MA, chief administrative officer for Anesthesiology & Perioperative Medicine
  • Mark Grichanik, PhD, MA, director of Program Evaluation
  • Charles Hajek, MBA, executive director of Finance
  • Daniel Kozman, MD, MPH, assistant dean for Justice, Equity and Diversity Inclusion
  • Alice Kuo, MD, PhD, professor and chief of Internal Medicine-Pediatrics and Preventive Medicine
  • David McIntosh, PhD, MA, vice dean for Justice, Equity, Diversity and Inclusion
  • Julian McNeil, M.S. Ed., program manager of the Anti-Racism Roadmap
  • Gerardo Moreno, MD, MPH, interim chair of Department of Family Medicine
  • Catherine Nameth, PhD, director of Faculty Professional Development
  • Mikel Whittier, DBA, director of Health Equity, Diversity and Inclusion

The selection of the DGSOM is a feather in our cap that affirms the work that we’re doing, and will also allow us to operationalize these efforts with another layer of structure.

Eraka Bath, MD